Next Article in Journal
Quantitative Assessment of Tissue Perfusion in Hepatocellular Carcinoma Using Perflubutane Dynamic Contrast-Enhanced Ultrasonography: A Preliminary Study
Previous Article in Journal
Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT
Previous Article in Special Issue
A Novel Point-of-Care Biomarker Recognition Method: Validation by Detecting Marker for Diabetic Nephropathy
Open AccessCommentary

Diagnostics for Developing Countries

TB Alert, Community Base, 113 Queens Road, Brighton, BN1 3XG, UK
Academic Editor: Sandeep Kumar Vashist
Diagnostics 2015, 5(2), 200-209;
Received: 23 March 2015 / Revised: 7 May 2015 / Accepted: 12 May 2015 / Published: 19 May 2015
(This article belongs to the Special Issue In Vitro Diagnostics)
Improving the availability of high quality diagnostic tests for infectious diseases is a global priority. Lack of access by people living in low income countries may deprive them of life saving treatment and reduces opportunities to prevent onward transmission and spread of the disease. Diagnostic laboratories are often poorly resourced in developing countries, and sparsely distributed. Improved access may be achieved by using tests that do not require laboratory support, including rapid tests for use at the point-of-care. Despite increased interest, few new in vitro diagnostic (IVD) products reach the majority populations in low income countries. Barriers to uptake include cost and lack of robustness, with reduced test performances due to environmental pressures such as high ambient temperatures or dust. In addition to environmental factors test developers must consider the local epidemiology. Confounding conditions such as immunosuppression or variations in antigen presentation or genotype can affect test performance. Barriers to product development include access to finance to establish manufacturing capacity and cover the costs of market entry for new devices. Costs and delays may be inflated by current regulatory preregistration processes to ensure product safety and quality, and more harmonized approaches are needed. View Full-Text
Keywords: IVD; point-of-care; tuberculosis; HIV; regulation; diagnostic test; infectious disease IVD; point-of-care; tuberculosis; HIV; regulation; diagnostic test; infectious disease
Show Figures

Figure 1

MDPI and ACS Style

McNerney, R. Diagnostics for Developing Countries. Diagnostics 2015, 5, 200-209.

AMA Style

McNerney R. Diagnostics for Developing Countries. Diagnostics. 2015; 5(2):200-209.

Chicago/Turabian Style

McNerney, Ruth. 2015. "Diagnostics for Developing Countries" Diagnostics 5, no. 2: 200-209.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop